http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002003397-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c31d756b30e9f6fe84a8d02899191b6c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
filingDate | 2000-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc7e3bef33c2db5fc975d1c3c15c2757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_788c2db2597ee66144abdd522e505268 |
publicationDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002003397-A |
titleOfInvention | Bleeding tendency treatment |
abstract | (57) Abstract: A therapeutic agent for bleeding tendency comprising, as an active ingredient, a series of heparin affinity peptides derived from a partial peptide of antithrombin III or a pharmaceutically acceptable salt thereof. According to the present invention, there is provided a therapeutic agent for bleeding tendency, which is useful for improving the bleeding tendency caused by heparin administered for suppressing blood coagulation during artificial dialysis or the like. |
priorityDate | 2000-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.